FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/07/014901 [Registered on: 17/07/2018] Trial Registered Prospectively
Last Modified On: 13/07/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   COMPARISON BETWEEN TWO DRUGS TO CHECK THE EFFECTIVENESS ON HEMODYNAMIC PARAMETERS 
Scientific Title of Study   A PROSPECTIVE RANDOMIZED COMPARATIVE STUDY OF INTRAVENOUS DEXEMEDETOMIDINE VERSUS MAGNESIUM SULPHATE [MgSO4] AS AN ADJUNCT DURING ANAESTHESIA FOR LAPROSCOPIC CHOLECYSTECTOMY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  shailee shah 
Designation  3 RD YEAR RESIDENT,ANESTHESIA 
Affiliation  SSG HOSPITAL,VADODARA 
Address  DEPARTMENT OF ANESTHESIA,SSG HOSPITAL,VADODARA
ROOM NO.58,NRMO HOSTEL,JAIL ROAD ,VADODARA
Vadodara
GUJARAT
390020
India 
Phone  9737458589  
Fax    
Email  dr.shahshailee16@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR DEVYANI DESAI 
Designation  ASSOCIATE PROFESSOR,ANESTHESIA 
Affiliation  SSG HOSPITAL,VADODARA 
Address  DEPARTMENT OF ANESTHESIA,SSG HOSPITAL,VADODARA
DEPARTMENT OF ANESTHESIA,SSG HOSPITAL,,VADODARA
Vadodara
GUJARAT
390020
India 
Phone  9909983168  
Fax    
Email  devyani.dr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  shailee shah 
Designation  3 RD YEAR RESIDENT,ANESTHESIA 
Affiliation  SSG HOSPITAL,VADODARA 
Address  DEPARTMENT OF ANESTHESIA,SSG HOSPITAL,VADODARA
ROOM NO.58,NRMO HOSTEL,JAIL ROAD ,VADODARA
Vadodara
GUJARAT
390020
India 
Phone  9737458589  
Fax    
Email  dr.shahshailee16@gmail.com  
 
Source of Monetary or Material Support  
SSG HOSPITAL ,VADODARA 
 
Primary Sponsor  
Name  SSG HOSPITAL VADODARA 
Address  DEPARTMENT OF ANAESTHESIA SSG HOSPITAL VADODARA 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SHAILEE SHAH  SSG HOSPITAL ,VADODARA  C1,C2,C3,C4,D1,D2,D3,D4 SURGICAL WARD ,NEW SURGICAL BLOCK ,SSG HOSPITAL VADODARA
Vadodara
GUJARAT 
9737458589

dr.shahshailee16@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee for Human Research, Medical College Baroda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ATTENUATION DURING ANESTHESIA IN LAPROSCOPIC CHOLECYSTECTOMY,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  INJ DEXMEDETOMIDINE   Inj Dexmedetomidine 1mcg/kg over 15 min in 20 ml NS intravenously  
Intervention  Inj magnesium sulphate  Inj magnesium sulphate 40mg/kg over 15 min in 20 ml NS intravenously 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1 Age Group 18 -65years
2 ASA status I & II
3 Male / female
Patients posted for laparoscopic cholecystectomy
 
 
ExclusionCriteria 
Details  • Anticipated difficult airway and obesity
• Patient having allergy to study drug
• Patient with systemic diseases like severe hypertension, cardiovascular, respiratory, neurological, psychological, hepatic, renal disease (diagnosed by clinical judgments and investigations) and on medication of above mentioned diseases
• Patients with heart rate <60 beats/mi
• Pregnant or lactating females
• Patients who refuse to give consent
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
It will be expected that both drugs will be effectively able to attenuate hemodynamic stress response during anaesthesia for laparoscopic cholecystectomy with CO2 pneumoperitoneum  1. Baseline
2. Before and after infusion
3. Before and after intubation
4. Before and after Pneumoperitoneum
5. After release of Pneumoperitoneum
6. After Extubation
 
 
Secondary Outcome  
Outcome  TimePoints 
1Amount of induction agent used
2Post-operative sedation –Ramsay sedation score
• Post-operative Analgesia-Visual analogue scale 
1min,15min,30min,60min,120min 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/07/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="10"
Days="30" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
70 patients of ASA status 1 and 2 ,aged between 18 to 65 years ,of either sex ,scheduled for laparoscopic cholecystectomy were randomized in 2 groups (group D and group M)in a single blind fashion ,to receive either dexmedetomidine1mcg/kg,magnesium sulphate 40mg/kg in normal saline iv respectively .Total volume of the study drug was adjusted to 20 ml and administered over 15 mins before induction .Aesthesia was induced with propofol till loss of eyelid reflex followed by inj succinylcholine 2mg/kg. Laryngoscopy  and intubation were done with appropriate size mac intosh blade and endotracheal tube .Hemodynamic parameters of patients including HR,SBP,RPP,MAP,SPO2,ETCO2,ECG were recorded at different time interval as below
          1 baseline
          2 before ad after infusion
          3 after intubation
          4 after pneumoperitoneum
          5 after release of pneumoperitoneum
          6 after extubation.

Post operative sedation and analgesia were assessed.
 
Close